| The MetNET-2 Trial (NCT02823691) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2016-04-01 |
| Preoperative Use of Tocotrienol From Annatto Bixa Orellana L. in Breast Cancer Patients: a Prospective Clinical Trial. (NCT04496492) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2016-02-09 |
| Dietary Intervention and BRCA Penetrance (NCT03066856) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-12-01 |
| Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses (NCT03620032) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-11-02 |
| Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention (NCT02869399) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-11-01 |
| Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery (NCT02535351) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-11-01 |
| Prospective Translational Study Investigating Possible Molecular prEdictors of Resistance to First-Line pazopanIb (NCT04462445) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-06-25 |
| Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC) (NCT02898415) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-06-01 |
| Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14 (NCT02860936) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-06-01 |
| Panitumumab-based Maintenance in Patients With RAS Wild-type, Metastatic Colorectal Cancer (Valentino) (NCT02476045) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-06-01 |
| Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers (NCT02867852) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-03-01 |
| Treatment of the Pancreatic Stump With Neoprene®-Based Glue After High-risk Pancreatoduodenectomy (NCT03738787) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-01-01 |
| A Randomized Double Blind Controlled Trial Comparing Sugammadex and Neostigmine After Thoracic Anesthesia (NCT02256280) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-01-01 |
| Preemptive Treatment With XONRID to Reduce Radiation Induced Dermatitis in Head and Neck Cancer Patients (NCT02261181) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-01-01 |
| Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14 (NCT02857712) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-12-01 |
| HIPEC Using High Intra-abdominal Pressure (NCT02949791) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-12-01 |
| Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study) (NCT03456401) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-11-01 |
| Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer (NCT02268747) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-11-01 |
| Phase II Study on Axitinib in Advanced Solitary Fibrous Tumor (NCT02261207) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-11-01 |
| Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients (NCT02414009) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-09-01 |
| Alisertib in Chemotherapy-pretreated Urothelial Cancer (NCT02109328) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-08-28 |
| Prevalence of Ocular Disorders in Multiple Myeloma (MM-OO-16) (NCT02917239) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-07-01 |
| Selective Axillary Lymph Node Dissection Vs Complete Axillary Dissection: A Randomised Clinical Trial to Assess the Prevention of Lymphedema in Breast Cancer Treatment (NCT03083314) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-06-12 |
| Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer (NCT02262221) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-06-01 |
| Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs (NCT02294006) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-06-01 |
| Molecular Profile of Metastatic Sporadic Medullary Thyroid Cancer Patients and Correlation With Vandetanib (NCT02268734) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-04-01 |
| Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel (NCT02290470) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-04-01 |
| Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome (NCT02960711) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-02-01 |
| Long Term Morbidity and Quality of Life in Retroperitoneal Sarcomas (NCT03480399) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-01-01 |
| Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients (NCT02099188) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-11-01 |
| Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients (NCT02099175) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-11-01 |
| TARC After alloSCT in Hodgkin's Lymphoma (NCT02069639) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-11-01 |
| Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients (NCT02547831) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-07-01 |
| Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis (NCT01728233) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-06-15 |
| PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES (NCT02086656) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-06-01 |
| Cyberknife After Breast Conservative Surgery (NCT02896322) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-06-01 |
| Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors (NCT01743482) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-05-17 |
| A Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens (NCT01869335) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-05-01 |
| Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine (NCT02479347) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-03-01 |
| Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial (NCT02176369) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-02-01 |
| Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study (NCT02247453) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-01-01 |
| Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets (NCT02353429) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2012-11-01 |
| Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen (NCT03844685) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2012-07-05 |
| Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer (NCT01914900) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2012-06-01 |
| PF-03446962 in Relapsed or Refractory Urothelial Cancer (NCT01620970) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2012-03-01 |
| Evaluation of Accelerometer-Based Neuromuscular Monitoring Reliability to Exclude Postoperative Residual Paralysis (NCT01503840) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2011-12-01 |
| Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases (NCT01444807) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2011-12-01 |
| Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging (NCT01387503) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2011-01-01 |
| Colorectal Cancer Detection by Means of Optical Fluoroscopy (NCT01286064) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2010-10-01 |
| High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy (NCT01172912) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2010-10-01 |
| Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder (NCT01222676) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2010-10-01 |
| Activity of Sorafenib in Salivary Gland Cancer (NCT01703455) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2010-09-01 |
| Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment (NCT01031875) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2009-12-01 |
| Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone (NCT01594047) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2009-12-01 |
| Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer (NCT02664974) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2008-12-01 |
| Prospective Observational Study on Plerixafor After Chemotherapy (NCT01700608) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2008-09-01 |
| A Questionnaire to Assess the Quality of Life of Rectal Cancer Patients With or Without Stoma (NCT01181557) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2008-09-01 |
| Whole Body Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) in Multiple Myeloma (NCT01829412) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2008-07-01 |
| Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study (NCT05019989) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2008-06-01 |
| Diagnosis of Rectal Cancer by Electromagnetic Device (NCT00963794) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2008-01-01 |
| Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma (NCT00910572) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2007-07-01 |
| Implant-based Breast Reconstruction and Mastectomy With Fat Grafting After Breast Conserving Surgery and Radiotherapy (NCT06119633) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2007-06-01 |
| Sentinel Node Biopsy Alone or With Axillary Dissection After Primary Chemotherapy (NCT04436809) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2007-01-01 |
| Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma (NCT01679860) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2006-11-01 |
| Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients (NCT02575859) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2006-01-01 |
| Early Lung Cancer Detection in High Risk Individuals (NCT02837809) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2005-09-01 |
| NAC Sparing Mastectomy After Neo-adjuvant Chemotherapy (NCT02471742) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2004-01-01 |
| Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast (NCT03002766) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2000-03-01 |
| Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer (NCT01508546) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1998-05-01 |
| Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors (NCT02161692) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1996-12-01 |
| Chemotherapy Plus Surgery in Treating Women With Breast Cancer (NCT00003013) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1996-10-01 |